From the culture broth of Streptomyces nodosus MH190-16F3, four new antibiotics have been isolated, and named saquayamycins A, B, C and D. The compounds are glycosides of aquayamycin, and among aquayamycin-group antibiotics they are most closely related to P-1894B (vineomycin A1). All saquayamycins act on Gram-positive bacteria and inhibit the growth of adriamycin-sensitive and adriamycin-resistant P388 leukemia cells.
In the course of our screening study for new antitumor antibiotics, which are effective on both adriamycin-sensitive (P388/S) and adriamycin-resistant (P388/ADR) sublines of P388 leukemia, new aquayamycinl'-group antibiotics were isolated from the culture broth of a strain classified as Streptomyces nodosus MH190-16F3. All these antibiotics consisted of aquayamycin (an aglycone) and three sugar molecules, and we named them saquayamycins A (1), B (2), C (3) and D (4) (Fig. 1 ). This paper describes the isolation, physical properties, structure elucidation and biological activities of the new antibiotics.
Results

Fermentation and Isolation Procedures
The producing strain was isolated from a soil sample collected in Tobata-ku, Kitakyushu, Japan.
Spores obtained from a well-sporulated slant of this organism were inoculated to the medium which consisted of 2.0% galactose, 2.0% dextrin, 1.0% Bacto-soytone (Difco), 0.5% corn steep liquor and 0.1 % CaCO3 (pH 7.4), and shake-cultured for 48 hours in a 500-m1 Erlenmeyer flask containing 110 ml of the medium described above. Thereafter 2 ml portions of the culture were inoculated to 500-m1
Erlenmeyer flasks containing 110 ml of the same medium to produce saquayamycins. Fermentation was carried out at 27°C under agitation on a rotary shaker at 180 rpm. After 72 hours, fermentation broth of each flask was combined and centrifuged to separate filtrate and mycelia. The production of the antibiotics was assayed by a cylinder-plate method testing for the activity against Micrococcus lysodeikticus IFO 3333. Various saquayamycins were detected by silica gel thin-layer chromatography (TLC) (Kieselgel 60 F254, Merck) developed with CHC13 -EtOAc -AcOH (10: 10: 0.1) and reversephase high performance liquid chromatography (Nucleosil SC18, Macherey-Nagel) with a mobile phase consisting of acetonitrile -0.02 M phosphate buffer (pH 3.0) (60: 40).
Active materials in the filtrate (8 liters) were extracted with BuOAc (8 liters) at pH 7.0, and concentrated in vacuo. From the crude dark brown powder (770 mg) thus obtained, saquayamycins A (32 mg) and B (45 mg) were isolated by silica gel column chromatography with CHC13 -EtOAc (100: 0-100: 4) followed by silica gel TLC with CHC13 -McOH (100: 2). The antibiotics in the THE JOURNAL OF ANTIBIOTICS SEPT. 1985 mycelia-cake were extracted with MeOH (1 liter) and concentrated to dryness. After washing with hexane, the residue was partitioned with BuOAc -H2O (1: 1) (1 liter), and the organic layer was concentrated in vacuo to give a dark brown crude powder (450 mg). From the curde powder, saquaya- Tables 1 and 2 , respectively. The 1H NMR data of saquayamycins A, B, C and D are shown in Table 3 .
The UV spectra in 0.1 w HCl -90% McOH were very similar to that of aquayamycin, and the IR, 1H NMR and 13C NMR spectra suggested the presence of hexose moieties .
Structure Elucidation of Saquayamycins
The structures of these saquayamycins have been determined by their spectral analysis and chemical degradation studies, which are summarized in Fig. 2 .
Mild methanolysis of 1 with 0.05 N HC1-McOH at room temperature for 5 minutes yielded a pigment 5 and a methyl glycoside 8, which were purified by silica gel TLC with benzene -EtOAc (3: 1).
The glycoside 8 was shown by direct comparison of its {a] D , Rf value on TLC and 1H NMR spectrum to be identical with a methyl disaccharide composed of L-rhodinose and L-aculose, which had been obtained from P-1894B2~ (vineomycin A13)) and ditrisarubicin C4). Comparing the 13C NMR spectra of 1 and 5, a down-field shift was observed with the C-3 in 1, but not with the C-4a and C-12b (Table   2 ). These data suggested that the disaccharide is attached to the C-3 in 1. The mode of the glycosidic linkage was indicated to be a by the coupling constant (J=3, N 1 Hz) of the anomeric proton at the C-lc' of 1. Table 5 . Effect of saquayamycins, aquayamycin and adriamycin on the growth of P388/S and P388/ADR leukemia cells. On the analysis of 1H NMR, 13C NMR and mass spectra of 6, its sugar component was demonstrated to be cinerulose B7,8) which is combined to the C-3' and C-4' of the aglycone part.
Based on these results, we propose the structures shown in Fig. 1 for saquayamycins A (1) , B (2), C (3), D (4), A l (5), B 1 (6) and C 1 (7).
Biological Activities
The antimicrobial activity of the antibiotics was examined by agar dilution method. As Table 4 shows, they act against Gram-positive bacteria, with MIC values between 1.56 and 6.25 ,u.g/ml. Table 5 shows the 50 % growth inhibition concentrations (IC50) of saquayamycins, aquayamycin and adriamycin against adriamycin-sensitive (P388/S) and adriamycin-resistant (P388/ADR) sublines of P388 leukemia cells9). The IC50 values of saquayamycins and aquayamycin against P388/ADR cells were nearly equal to those against P388/S cells, respectively. The LD50 by intraperitoneal injection of saquayamycins A and B in mice were 6.25-12.5 mg/kg.
Discussion
As described above, saquayamycins A, B, C and D produced by Streptomyces nodosus MH190-16F3 are the antibiotics which belong to aquayamycin-group.
Ayamycin A210) and TA-435 A11) have been reported to have the same UV spectra. Therefore, we tested their Rf values on silica gel TLC, and confirmed that they should be different from saquayamycins.
Judging from the 13C chemical shift assignments of saquayamycin A, the '3C chemical shifts assigned to C-3, 4a, 12b, 2', 4', 6', 4", 4a', 5", 5a', 5" and 5a" in P-1894B°~ should be changed to C-12b, 3 4a 6' 4" or 4a' 4a' or 4" 5a' 5" 5a" or 5"5" or 5a" 2' or 4' and 4' or 2' respectively (This numbering follows that of P-1894B reported by OHTA et al.2').
Experimental
General Melting points were determined on a Yanagimoto micro-melting point apparatus and are uncorrected. Optical rotations were measured with a Perkin-Elmer 241 polarimeter. IR spectra were recorded with a Hitachi 260-10 spectrometer. UV spectra were taken on a Hitachi 220S spectrometer. 1H and 13C NMR spectra were recorded with a Jeol GX-400 spectrometer at 400 MHz (1H) and 100 MHz (13C), respectively. Chemical shifts are expressed in o values (ppm) with TMS as an internal reference and coupling constants are given in Hz (J). The following abbreviations are used: s =singlet, d=doublet, dd=doublet of doublets, ddd=doublet of doublets of doublets, dddd=doublet of doublets of doublets of doublets, t =triplet, q =quartet, dq =doublet of quartets, br d =broad doublet and m = multiplet. 13C Chemical shift assignments were made by carbon-proton chemical shift correlation experiments and long-range selective proton decoupling experiments. Mass spectra were determined with a Hitachi RMU-6M apparatus (EI-MS) or a Hitachi RMU-7M apparatus (FD-MS). TLC was carried out on silica gel plate (Kieselgel 60 F254, Merck) and column chromatography was carried out with silica gel (Kieselgel 60, Merck).
Partial Hydrolysis of Saquayamycins A, B, C and D Each saquayamycin solution in acetonitrile -0.2% phosphoric acid (60: 40) was kept at 37°C for 2 hours, and extracted with CHC13. After washing with H2O, the solvent layer was dried over Na2SO4, and concentrated to dryness. The pigment thus obtained was purified by silica gel plates with CHCl3 -MeOH (100:3). Thus, saquayamycin A (1) (20 mg), B (2) (20 mg), C (3) (40 mg) and D (4) (4 mg) gave saquayamycin Al (5) (8 mg), B1 (6) (13 mg), C1 (7) (27 mg) and B1 (6) Catalytic Hydrogenation of Saquayamycin A (1) A solution of 1 (80 mg) in EtOAc (10 ml) and McOH (10 ml) was hydrogenated with 5 % Pd/ BaSO4 (100 mg) at room temperature for 15 minutes. The catalyst was filtered off and the fitrate was concentrated in vacuo. The yellow brown powder thus obtained were purified by silica gel TLC with CHC13 -McOH (3: 1) to yield saquayamycin C (3) (50 mg).
Mild Methanolysis of Saquayamycin C (3) 3 (40 mg) was dissolved in 0.05 N HCl -McOH (10 ml), allowed to stand at room temperature for 5 minutes, and neutralized with Ag2CO3 (50 mg). After filtration, the filtrate was concentrated and chromatographed on silica gel plates with benzene -EtOAc (2: 1) to give saquayamycin C1 (7) (11 mg) and compound 9 (3.5 mg). Catalytic Hydrogenation of Compound 8 8 (4.0 mg) was dissolved in EtOAc (2 ml) and McOH (2 ml), and hydrogenated over 5 % Pd/BaSO4 (10 mg) at room temperature and atmospheric pressure for 10 minutes. The reaction mixture was filtered, evaporated to dryness, and purified by silica gel TLC with benzene -EtOAc (2: 1) to yield 9 (2.8 mg).
Identity of Compound 11 with p-Nitrophenylhydrazone of Methyl a-L-Cinerulose A A solution of 7 (20 mg) in MeOH (8 ml) was mixed with p-nitrophenylhydrazine hydrochloride (8 mg) in H2O (0.9 ml) and pyridine (0.05 ml). The resulting mixture was kept at 50°C for 20 minutes,
